Composition, form of production and packaging
? Aerosol for topical application in the form of a homogeneous suspension of white with a yellowish tint of color, with a characteristic odor of anise.
1 f. (30 g)
biclutimol 750 mg
Excipients: benzyl alcohol, disodium edetate, methylparaben, anisic oil, ammonium glycyrrhizinate, sodium saccharin, Avicel RC 591 (microcrystalline cellulose and sodium carboxymethylcellulose), soy lecithin, glycerol, ethanol 95%, purified water.
30 g - plastic bottles with plastic coating (1) with a spray valve - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
Antiseptic for topical application in ENT practice. It is active against staphylococci, streptococci and corynebacteria, has a local anesthetic and anti-inflammatory effect.
When topical application is characterized by prolonged action.
PHARMACOKINETICS
Studies of the pharmacokinetics of the Hexaspree preparation have not been carried out.
INDICATIONS
Local treatment of infectious and inflammatory diseases of the oral cavity, pharynx and larynx caused by microorganisms sensitive to biclothymol, including:
- Acute and chronic pharyngitis;
- pharyngolaringitis;
- tonsillitis;
- condition after tonsillectomy;
glossitis.
DOSING MODE
The drug is administered inhalation for 2 injections 3 times / day, regardless of food intake.
During the inhalation, the bottle should be kept upright. Shake the bottle before use.
SIDE EFFECT
Possible: allergic reactions.
CONTRAINDICATIONS
- children's age till 6 years;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
Possible use of the drug during pregnancy and lactation (breastfeeding).
APPLICATION FOR CHILDREN
Contraindication: children under 6 years.
SPECIAL INSTRUCTIONS
If the therapeutic effect is absent or weak within 5 days, the therapy should be reviewed.
OVERDOSE
At present, there have been no reports of overdose of the Hexaspree drug.
DRUG INTERACTION
It is necessary to avoid simultaneous use of other medications for topical application in the oral cavity.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of the reach of children at a temperature of no higher than 25 В° C. Shelf life - 5 years.
